Skip to main content
Erschienen in: Supportive Care in Cancer 4/2012

01.04.2012 | Original Article

Fatigue assessment and rehabilitation outcomes in patients with brain tumors

verfasst von: Bo Ryun Kim, Min Ho Chun, Eun Young Han, Don-Kyu Kim

Erschienen in: Supportive Care in Cancer | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

Objectives

This study seeks to investigate the fatigue severity and the relationship among fatigue and other associated factors in patients with brain tumors, and to evaluate the rehabilitation outcome on fatigue.

Design

We assessed 25 patients in whom brain tumors had been resected and transferred to the rehabilitation department of our hospital. Patients were evaluated for fatigue severity using the Piper Fatigue Scale (PFS) and the Brief Fatigue Inventory (BFI), for mood using the Beck Depression Inventory, for motor function using the Motricity Index (MI), for functional status using the Karnofsky Performance Status (KPS) scale and the Modified Barthel Index (MBI), and for quality-of-life using the European Organization for Research and Treatment of Cancer Quality-of-Life Questionnaire-Core 30 (EORTC QLQ-C30). We also measured the levels of serum hemoglobin, C-reactive protein, albumin, and creatine kinase; and anthropometric variables before and 4 weeks after rehabilitation.

Results

Of the 25 patients, 21 (84.0%) reported fatigue during the previous week. The average PFS score was 4.6 ± 1.8 and the average BFI score 5.2 ± 2.2, indicating the moderate level of fatigue. Patients with recurrent tumors had significantly higher PFS scores than did those with initial tumors. Fatigue correlated significantly with the KPS, MBI, and EORTC QLQ-C30 physical functioning and insomnia scales. In addition, insomnia was a significant predictor of fatigue before rehabilitation, and the baseline fatigue scales, MBI, MI, and EORTC QLQ-C30 physical functioning scale were the important independent predictors of fatigue after rehabilitation. During rehabilitation, the KPS, MBI, and MI scores improved significantly, whereas total PFS and BFI scores did not change.

Conclusions

These findings suggest that patients with brain tumors commonly complain of moderate level of fatigue, which may reduce daily functioning and quality of life, with sleep disturbance being a significant predictor of fatigue. During rehabilitation, functional outcomes and motor power showed improvements in those patients, not aggravating fatigue.
Literatur
1.
Zurück zum Zitat Mock V, Atkinson A, Barsevick A et al (2000) NCCN practice guidelines for cancer-related fatigue. Oncology (Williston Park) 14:151–161 Mock V, Atkinson A, Barsevick A et al (2000) NCCN practice guidelines for cancer-related fatigue. Oncology (Williston Park) 14:151–161
2.
Zurück zum Zitat Cella D, Davis K, Breitbart W, Curt G (2001) Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol 19:3385–3391PubMed Cella D, Davis K, Breitbart W, Curt G (2001) Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol 19:3385–3391PubMed
3.
Zurück zum Zitat Lawrence DP, Kupelnick B, Miller K, Devine D, Lau J (2004) Evidence report on the occurrence, assessment, and treatment of fatigue in cancer patients. J Natl Cancer Inst Monogr 32:40–50PubMedCrossRef Lawrence DP, Kupelnick B, Miller K, Devine D, Lau J (2004) Evidence report on the occurrence, assessment, and treatment of fatigue in cancer patients. J Natl Cancer Inst Monogr 32:40–50PubMedCrossRef
4.
Zurück zum Zitat Prue G, Rankin J, Allen J, Gracey J, Cramp F (2006) Cancer-related fatigue: a critical appraisal. Eur J Cancer 42:846–863PubMedCrossRef Prue G, Rankin J, Allen J, Gracey J, Cramp F (2006) Cancer-related fatigue: a critical appraisal. Eur J Cancer 42:846–863PubMedCrossRef
5.
Zurück zum Zitat Ryan JL, Carroll JK, Ryan EP, Mustian KM, Fiscella K, Morrow GR (2007) Mechanisms of cancer-related fatigue. Oncologist 12(Suppl 1):22–34PubMedCrossRef Ryan JL, Carroll JK, Ryan EP, Mustian KM, Fiscella K, Morrow GR (2007) Mechanisms of cancer-related fatigue. Oncologist 12(Suppl 1):22–34PubMedCrossRef
6.
Zurück zum Zitat Morrow GR, Shelke AR, Roscoe JA, Hickok JT, Mustian K (2005) Management of cancer-related fatigue. Cancer Investig 23:229–239CrossRef Morrow GR, Shelke AR, Roscoe JA, Hickok JT, Mustian K (2005) Management of cancer-related fatigue. Cancer Investig 23:229–239CrossRef
7.
Zurück zum Zitat Spelten ER, Verbeek JH, Uitterhoeve AL et al (2003) Cancer, fatigue and the return of patients to work—a prospective cohort study. Eur J Cancer 39:1562–1567PubMedCrossRef Spelten ER, Verbeek JH, Uitterhoeve AL et al (2003) Cancer, fatigue and the return of patients to work—a prospective cohort study. Eur J Cancer 39:1562–1567PubMedCrossRef
8.
Zurück zum Zitat Mormont MC, Waterhouse J, Bleuzen P et al (2000) Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status. Clin Cancer Res 6:3038–3045PubMed Mormont MC, Waterhouse J, Bleuzen P et al (2000) Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status. Clin Cancer Res 6:3038–3045PubMed
9.
Zurück zum Zitat Song DS, Yeo CD, Park JM et al (2007) The prevalence of fatigue in cancer patients at St. Vincent's hospital. Korean J Med 73:512–518 Song DS, Yeo CD, Park JM et al (2007) The prevalence of fatigue in cancer patients at St. Vincent's hospital. Korean J Med 73:512–518
10.
Zurück zum Zitat Yang YH (2003) Relationship between fatigue and nutritional status in patients with cancer undergoing radiotherapy. Taehan Kanho Hakhoe Chi 33:478–487PubMed Yang YH (2003) Relationship between fatigue and nutritional status in patients with cancer undergoing radiotherapy. Taehan Kanho Hakhoe Chi 33:478–487PubMed
11.
Zurück zum Zitat Schwartz AL, Mori M, Gao R, Nail LM, King ME (2001) Exercise reduces daily fatigue in women with breast cancer receiving chemotherapy. Med Sci Sports Exerc 33:718–723PubMedCrossRef Schwartz AL, Mori M, Gao R, Nail LM, King ME (2001) Exercise reduces daily fatigue in women with breast cancer receiving chemotherapy. Med Sci Sports Exerc 33:718–723PubMedCrossRef
12.
Zurück zum Zitat Oldervoll LM, Kaasa S, Knobel H, Loge JH (2003) Exercise reduces fatigue in chronic fatigued Hodgkins disease survivors—results from a pilot study. Eur J Cancer 39:57–63PubMedCrossRef Oldervoll LM, Kaasa S, Knobel H, Loge JH (2003) Exercise reduces fatigue in chronic fatigued Hodgkins disease survivors—results from a pilot study. Eur J Cancer 39:57–63PubMedCrossRef
13.
Zurück zum Zitat Segal RJ, Reid RD, Courneya KS et al (2003) Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol 21:1653–1659PubMedCrossRef Segal RJ, Reid RD, Courneya KS et al (2003) Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol 21:1653–1659PubMedCrossRef
14.
Zurück zum Zitat Tang V, Rathbone M, Park Dorsay J, Jiang S, Harvey D (2008) Rehabilitation in primary and metastatic brain tumours: impact of functional outcomes on survival. J Neurol 255:820–827PubMedCrossRef Tang V, Rathbone M, Park Dorsay J, Jiang S, Harvey D (2008) Rehabilitation in primary and metastatic brain tumours: impact of functional outcomes on survival. J Neurol 255:820–827PubMedCrossRef
15.
Zurück zum Zitat O'Dell MW, Barr K, Spanier D, Warnick RE (1998) Functional outcome of inpatient rehabilitation in persons with brain tumors. Arch Phys Med Rehabil 79:1530–1534PubMedCrossRef O'Dell MW, Barr K, Spanier D, Warnick RE (1998) Functional outcome of inpatient rehabilitation in persons with brain tumors. Arch Phys Med Rehabil 79:1530–1534PubMedCrossRef
16.
Zurück zum Zitat Kang YW, Na DL, Han SH (1997) A Validation study on the Korean Mini-Mental State Examination (K-MMSE) in dementia patients. J Korean Neurol Assoc 15:300–308 Kang YW, Na DL, Han SH (1997) A Validation study on the Korean Mini-Mental State Examination (K-MMSE) in dementia patients. J Korean Neurol Assoc 15:300–308
17.
Zurück zum Zitat Piper BF, Dibble SL, Dodd MJ, Weiss MC, Slaughter RE, Paul SM (1998) The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer. Oncol Nurs Forum 25:677–684PubMed Piper BF, Dibble SL, Dodd MJ, Weiss MC, Slaughter RE, Paul SM (1998) The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer. Oncol Nurs Forum 25:677–684PubMed
18.
Zurück zum Zitat Lee EH (1999) Construct validity of the Revised Piper Fatigue Scale in Korean women with breast cancer. J Korean Acad Nurs 29:485–493 Lee EH (1999) Construct validity of the Revised Piper Fatigue Scale in Korean women with breast cancer. J Korean Acad Nurs 29:485–493
19.
Zurück zum Zitat Yun YH, Wang XS, Lee JS et al (2005) Validation study of the Korean version of the brief fatigue inventory. J Pain Symptom Manage 29:165–172PubMedCrossRef Yun YH, Wang XS, Lee JS et al (2005) Validation study of the Korean version of the brief fatigue inventory. J Pain Symptom Manage 29:165–172PubMedCrossRef
20.
Zurück zum Zitat Jo SA, Park MH, Jo I, Ryu SH, Han C (2007) Usefulness of Beck Depression Inventory (BDI) in the Korean elderly population. Int J Geriatr Psychiatry 22:218–223PubMedCrossRef Jo SA, Park MH, Jo I, Ryu SH, Han C (2007) Usefulness of Beck Depression Inventory (BDI) in the Korean elderly population. Int J Geriatr Psychiatry 22:218–223PubMedCrossRef
21.
Zurück zum Zitat Collin C, Wade D (1990) Assessing motor impairment after stroke: a pilot reliability study. J Neurol Neurosurg Psychiatry 53:576–579PubMedCrossRef Collin C, Wade D (1990) Assessing motor impairment after stroke: a pilot reliability study. J Neurol Neurosurg Psychiatry 53:576–579PubMedCrossRef
22.
Zurück zum Zitat Schag CC, Heinrich RL, Ganz PA (1984) Karnofsky performance status revisited: reliability, validity, and guidelines. J Clin Oncol 2:187–193PubMed Schag CC, Heinrich RL, Ganz PA (1984) Karnofsky performance status revisited: reliability, validity, and guidelines. J Clin Oncol 2:187–193PubMed
23.
Zurück zum Zitat Jung HY, Park BK, Shin HS et al (2007) Development of the Korean version of Modified Barthel Index (K-MBI): multi-center study for subjects with stroke. J Korean Acad Rehabil Med 31:283–297 Jung HY, Park BK, Shin HS et al (2007) Development of the Korean version of Modified Barthel Index (K-MBI): multi-center study for subjects with stroke. J Korean Acad Rehabil Med 31:283–297
24.
Zurück zum Zitat Yun YH, Park YS, Lee ES et al (2004) Validation of the Korean version of the EORTC QLQ-C30. Qual Life Res 13:863–868PubMedCrossRef Yun YH, Park YS, Lee ES et al (2004) Validation of the Korean version of the EORTC QLQ-C30. Qual Life Res 13:863–868PubMedCrossRef
25.
Zurück zum Zitat Fayers P, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A (2001) The EORTC QLQ-C30 scoring manual. The EORTC QLQ-C30 scoring manual, Brussels Fayers P, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A (2001) The EORTC QLQ-C30 scoring manual. The EORTC QLQ-C30 scoring manual, Brussels
26.
Zurück zum Zitat Fayers P, Weeden S, Curran D (1998) EORTC QLQ-C30 reference values. EORTC Quality of Life Study Group, Belgium Fayers P, Weeden S, Curran D (1998) EORTC QLQ-C30 reference values. EORTC Quality of Life Study Group, Belgium
27.
28.
Zurück zum Zitat Pater JL, Zee B, Palmer M, Johnston D, Osoba D (1997) Fatigue in patients with cancer: results with National Cancer Institute of Canada Clinical Trials Group studies employing the EORTC QLQ-C30. Support Care Cancer 5:410–413PubMedCrossRef Pater JL, Zee B, Palmer M, Johnston D, Osoba D (1997) Fatigue in patients with cancer: results with National Cancer Institute of Canada Clinical Trials Group studies employing the EORTC QLQ-C30. Support Care Cancer 5:410–413PubMedCrossRef
29.
Zurück zum Zitat Berger AM (1998) Patterns of fatigue and activity and rest during adjuvant breast cancer chemotherapy. Oncol Nurs Forum 25:51–62PubMed Berger AM (1998) Patterns of fatigue and activity and rest during adjuvant breast cancer chemotherapy. Oncol Nurs Forum 25:51–62PubMed
30.
Zurück zum Zitat Huang ME, Wartella JE, Kreutzer JS (2001) Functional outcomes and quality of life in patients with brain tumors: a preliminary report. Arch Phys Med Rehabil 82:1540–1546PubMedCrossRef Huang ME, Wartella JE, Kreutzer JS (2001) Functional outcomes and quality of life in patients with brain tumors: a preliminary report. Arch Phys Med Rehabil 82:1540–1546PubMedCrossRef
Metadaten
Titel
Fatigue assessment and rehabilitation outcomes in patients with brain tumors
verfasst von
Bo Ryun Kim
Min Ho Chun
Eun Young Han
Don-Kyu Kim
Publikationsdatum
01.04.2012
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 4/2012
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-011-1153-5

Weitere Artikel der Ausgabe 4/2012

Supportive Care in Cancer 4/2012 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.